TLR7 and COVID-19: In conclusion, these findings indicate that patients with severe SARS-CoV-2 infection, including those characterized by increased levels of blood inflammatory markers and/or the presence of secondary bacterial superinfections and non-survivors of COVID-19, had altered expression of IFNλ subtypes, IFNγ and TLR3, TLR7 and TLR8.